The stock is coming good, right when the bottom of the market is looking a lot better.
-Phase 2 results imminent
-FDA pre submission results due
-Their strategic US advisor has had time in the role now, so interesting to see what he can produce.
When Resapp was at the same stage they were a $200m MC company, TRI still on capped at $15m.
A lot to look forward to with a runway built to really launch the company from here.
Ann: Completion of Phase 2 SAMDE Trial, page-7
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
